Molecular genetics as the route to understanding, prevention, and treatment

Lancet

Volumn 348, Issue SUPPL.1, 1996, Pages

  Hamsten, Anders ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MARKER;

AGING; ARTICLE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE THERAPY; GENETIC LINKAGE; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; MOLECULAR GENETICS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RISK;

EID: 0029801487     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)98006-X     Document Type: Article

References (14)

1. Dammerman M, Breslow JL. Genetic basis of lipoprotein disorders. Circulation 1995; 91: 505-12.
2. Genest JJ Jr, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2025-33.
3. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992; 90: 52-60.
4. Green F, Humphries S. Fibrinolysis. Baittière's Clin Haematol 1995; 8(2): 345-63.
5. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-94.
6. Katsuya T, Koike G, Yee TW, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-03.
7. Singer DRJ, Missouris CG, Jeffrey S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion? Circulation 1996; 94: 236-39.
8. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
9. Ruiz J, Blanché H, James RW, et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869-72.
10. Kontula K, Ehnholm C. Regulatory mutations in human lipoprotein disorders and atherosclerosis. Curr Opin Lipidol 1996; 7: 64-68.
11. Eriksson P, Kallin B, Van't Hooft F, Båvenholm P, Hamsten A. Allele-specific increase in basal PAI-1 transcription associated with myocardial infarcton. Proc Natl Acad Sci USA 1995; 92: 1851-55.
12. Ye S, Eriksson P, Hamsten A, Humphries SE, Kurkinen M, Henney AM. Functional analysis of a common genetic variant in the human stromelysin-1 gene promoter. J Biol Ghent 1996; 271: 13055-60.
13. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37: 907-25.
14. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-60.